LUXFER HOLDINGS PLC (LXFR)
Industrial Inorganic Chemicals · Healthcare · $487M
Intrinsic Value (Consensus)
$7.01
Current Price
$18.19
Margin of Safety
-61.5%
61.5% Above Intrinsic Value
Value: $7
Price: $18
Valuation Model Estimates
Current Price: $18.19
DCF (Discounted Cash Flow)
$12.42
Graham Number
$7.30
Earnings Power Value
$2.72
Relative Value (P/E)
$5.60
Dividend Discount Model
$1.57
Consensus Value
$7.01
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
47
Profitability
12/25
Strength
24/25
Valuation
7/25
Growth
4/25
Financial Health Signals
Declining revenue — top line is shrinking
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $0.28
- EPS (Forward)
- $0.29
- Book Value
- $8.46
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 3.4%
- Debt/Equity
- 17%
- Revenue Growth
- -1.9%
- Earnings Growth
- 2.0%
- Dividend Yield
- 2.3%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance